DexKo Global Announces CEO Transition; Eric McGinnis Appointed Chief Executive Officer
Bentley, a founding leader of DexKo, has served as CEO for more than ten years and has been instrumental in building the company into a leading global provider of highly engineered components, with a strong reputation for operational excellence and customer service.
"DexKo is a strong and well-positioned company, and the time is right to transition leadership as part of our long-term succession planning," said Bentley. "Eric brings a proven track record of driving performance in complex global industrial businesses, and I have full confidence in his ability to lead DexKo forward."
McGinnis most recently served as Corporate Officer and President of Climate Solutions at Modine Manufacturing Company. In that role, he led a global business through significant revenue growth, margin expansion, and operational transformation.
"I'm honored to join DexKo at such an exciting time," said McGinnis. "The company has a strong foundation, talented teams, and a clear focus on customers. I look forward to working with the team to build on that momentum and continue strengthening the business."
As Chairman of the Board, Bentley will remain actively engaged in supporting the company's strategy and leadership transition.
Please send inquiries to: Phone: 574.295.7888 |
Phone: 574.296.7228 |
DexKo Global Inc. is the world's largest manufacturer and specialty distributor of highly-engineered solutions critical to the safety and performance of towable applications. DexKo Global was founded at the end of 2015 through the combination of DEXTER and AL-KO Vehicle Technology. With its headquarters in
View original content to download multimedia:https://www.prnewswire.com/news-releases/dexko-global-announces-ceo-transition-eric-mcginnis-appointed-chief-executive-officer-302818453.html
SOURCE DexKo Global Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nanochon Performs First Case in the Chondrograft™ First in Human Clinical Study
- Vanda Pharmaceuticals Announces Participation at September 2026 Investor Conferences
- Ares Management Corporation to Present at the Barclays Global Financial Services Conference
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share